Close Menu
Home » MolecularMD to Offer Promega Microsatellite Instability Technology

MolecularMD to Offer Promega Microsatellite Instability Technology

Nov 14, 2017
|
staff reporter

NEW YORK (GenomeWeb) – MolecularMD announced today that it will now provide Promega's Microsatellite Instability (MSI) v1.2 Analysis System as part of a larger portfolio of diagnostic and clinical research products aimed at supporting the development of oncology drugs and clinical trials.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Letting Samples Fly

Rady Children's Institute for Genomic Medicine and Deloitte are looking into the use of drones to transport samples for testing. 

Layoffs at 23andMe

Direct-to-consumer genetic testing firm 23andMe is laying off about 100 people.

Dusty Resistance

Researchers from Northwestern University examined dust for antibiotic-resistance genes, New Scientist reports. 

Science Studies Use Single-Cell RNA Sequencing to Study Cell States, Apply Deep Phenotyping to Pregnancy

In Science this week: researchers present a computational method for predicting cellular differentiation state from single-cell RNA sequencing data, and more. 

What's Popular?

In Business News

  1. 23andMe Lays off 100 Employees Across Consumer Business

  2. 10x Genomics Lawsuit Over Exclusivity of Harvard Single-Cell IP License Going to Trial

  3. Adaptive Biotechnologies Prices Public Offering of Stock

  4. Federal Court Whittles Down Fluidigm Lawsuit Against IonPath

  5. Quest Diagnostics Acquires Blueprint Genetics

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.